COVID-19: PCORI-funded study to assess antimalarial drug’s ability to prevent coronavirus infection

WASHINGTON (April 1, 2020) – The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors today approved up to $50 million to fund a registry and randomized clinical trial of the effectiveness of hydroxychloroquine (HCQ) in preventing COVID-19 infections in U.S. healthcare workers. The registry will create a community of healthcare workers (HCWs) interested in contributing…

Outcomes of coronavirus patients treated with extracorporeal membrane oxygenation in China offers guidance for management of critically ill COVID-19 patients worldwide

April 1, 2020 – The initial experience of extracorporeal membrane oxygenation (ECMO) management for coronavirus 2019 (COVID-19) patients in Shanghai, China provides guidance for management of critically ill COVID-19 patients worldwide, reports a study in the ASAIO Journal. The journal is published in the Lippincott portfolio by Wolters Kluwer. For the most critically ill COVID-19…

AGA issues formal recommendations for PPE during gastrointestinal procedures

Bethesda, Maryland (April 1, 2020) — Today, the American Gastroenterological Association (AGA) published new COVID-19 recommendations in Gastroenterology, the official journal of the AGA: AGA Institute Rapid Recommendations for Gastrointestinal Procedures During the COVID-19 Pandemic. This rapid recommendation document was commissioned and approved by the AGA Institute Clinical Guidelines Committee, AGA Institute Clinical Practice Updates…

Tracking tau

In the fight against neurodegenerative diseases such as frontotemporal dementia, Alzheimer’s and Chronic Traumatic Encephalopathy, the tau protein is a major culprit. Found abundantly in our brain cells, tau is normally a team player — it maintains structure and stability within neurons, and it helps with transport of nutrients from one part of the cell…